Home / Medical Equipments / Canada Orthobiologics Market Outlook to 2025

Canada Orthobiologics Market Outlook to 2025

Published: Jul 2018 | Published By: GlobalData

Summary

GlobalDatas new report, Canada Orthobiologics Market Outlook to 2025, provides key market data on the Canada Orthobiologics market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market categories - Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Orthobiologics market categories - Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation.
- Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2015 to 2025.
- 2017 company share and distribution share data for Orthobiologics market.
- Global corporate-level profiles of key companies operating within the Canada Orthobiologics market.
- Key players covered include Medtronic plc, Sanofi, Stryker Corp and Others.

Reasons to buy

- Develop business strategies by identifying the key market categories poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
- What are the key distribution channels and whats the most preferred mode of product distribution - Identify, understand and capitalize.

1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4

2 Introduction 5
2.1 What Is This Report About? 5
2.2 Orthobiologics Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6

3 Orthobiologics Market, Canada 9
3.1 Orthobiologics Market, Canada, Revenue ($m), 2015-2025 9
3.1.1 Bone Grafts and Substitutes Market, Canada, Revenue ($m), by Segment, 2015-2025 12
3.1.2 Bone Growth Stimulators Market, Canada, Revenue ($m), by Segment, 2015-2025 14
3.1.3 Soft Tissue Biologics Market, Canada, Revenue ($m), by Segment, 2015-2025 16
3.1.4 Viscosupplementation Market, Canada, Revenue ($m), by Segment, 2015-2025 18
3.2 Orthobiologics Market, Canada, Volume (Units), 2015-2025 20
3.2.1 Bone Grafts and Substitutes Market, Canada, Volume (Units), by Segment, 2015-2025 22
3.2.2 Bone Growth Stimulators Market, Canada, Volume (Units), by Segment, 2015-2025 25
3.2.3 Soft Tissue Biologics Market, Canada, Volume (Units), by Segment, 2015-2025 27
3.2.4 Viscosupplementation Market, Canada, Volume (Units), by Segment, 2015-2025 29
3.3 Orthobiologics Market, Canada, Average Price ($), 2015-2025 32
3.4 Orthobiologics Market, Canada, Distribution Share by Revenue ($m), 2017 34
3.5 Orthobiologics Market, Canada, Company Share by Revenue ($m), 2017 35

4 Overview of Key Companies in Canada, Orthobiologics Market 37
4.1 Medtronic Plc 37
4.1.1 Company Overview 37
4.2 Sanofi 37
4.2.1 Company Overview 37
4.3 DePuy Synthes Inc 37
4.3.1 Company Overview 37
4.4 Stryker Corp 37
4.4.1 Company Overview 37
4.5 Zimmer Biomet Holdings Inc 38
4.5.1 Company Overview 38
4.6 Aralez Pharmaceuticals Inc 38
4.6.1 Company Overview 38
4.7 ConMed Corporation 38
4.7.1 Company Overview 38
4.8 DJO Global Inc 39
4.8.1 Company Overview 39
4.9 RTI Surgical Inc 39
4.9.1 Company Overview 39
4.10 LifeNet Health Inc 39
4.10.1 Company Overview 39
4.11 Bioventus LLC 39
4.11.1 Company Overview 39
4.12 Ferring Pharmaceuticals A/S 40
4.12.1 Company Overview 40
4.13 Wright Medical Group NV 40
4.13.1 Company Overview 40
4.14 Orthofix Holdings Inc 40
4.14.1 Company Overview 40

5 Orthobiologics Market Pipeline Products 41

6 Financial Deals Landscape 43
6.1 Equity Offerings 43
6.1.1 Ortho Regenerative Technologies to Raise USD1.5 Million in Private Placement of Shares 43
6.1.2 Ortho Regenerative Technologies Raises Funds through Private Placement of Shares and Warrants 44
6.1.3 Ortho Regenerative Technologies Raises Additional USD0.1 Million in Private Placement of Units 45
6.1.4 Ortho Regenerative Technologies Raises USD0.7 Million in First Tranche Private Placement of Units 46

7 Recent Developments 47
7.1 Corporate Communications 47
7.1.1 Jan 08, 2018: Ortho RTi Announces Changes to its Board of Directors 47
7.1.2 Dec 19, 2017: Ortho RTi Expands Scientific Advisory Board with Appointment of Accomplished Orthopedic Surgeon, Dr. Jacques Toueg 47
7.1.3 Aug 29, 2017: Accomplished Pharmaceutical Industry Executive Joins Ortho Regenerative Technologies as VP of Product Development 48

8 Appendix 49
8.1 Research Methodology 50
8.1.1 Coverage 50
8.1.2 Secondary Research 50
8.1.3 Primary Research 51
8.1.4 Market Modeling and Forecasting 52
8.1.5 Company Share Analysis 53
8.1.6 Distribution Share Analysis 54
8.1.7 Benchmarking 54
8.2 GlobalData Consulting 54
8.3 Contact Us 55
8.4 Disclaimer 55

Table 1: Orthobiologics Market, Canada, Revenue ($m), USD Constant, 2015-2020 10
Table 2: Orthobiologics Market, Canada, Revenue ($m), USD Constant, 2021-2025 11
Table 3: Bone Grafts and Substitutes Market, Canada, Revenue ($m), USD Constant, 2015-2020 13
Table 4: Bone Grafts and Substitutes Market, Canada, Revenue ($m), USD Constant, 2021-2025 13
Table 5: Bone Growth Stimulators Market, Canada, Revenue ($m), USD Constant, 2015-2020 15
Table 6: Bone Growth Stimulators Market, Canada, Revenue ($m), USD Constant, 2021-2025 15
Table 7: Soft Tissue Biologics Market, Canada, Revenue ($m), USD Constant, 2015-2020 17
Table 8: Soft Tissue Biologics Market, Canada, Revenue ($m), USD Constant, 2021-2025 17
Table 9: Viscosupplementation Market, Canada, Revenue ($m), USD Constant, 2015-2020 19
Table 10: Viscosupplementation Market, Canada, Revenue ($m), USD Constant, 2021-2025 19
Table 11: Orthobiologics Market, Canada, Volume (Units), 2015-2020 21
Table 12: Orthobiologics Market, Canada, Volume (Units), 2021-2025 21
Table 13: Bone Grafts and Substitutes Market, Canada, Volume (Units), 2015-2020 23
Table 14: Bone Grafts and Substitutes Market, Canada, Volume (Units), 2021-2025 24
Table 15: Bone Growth Stimulators Market, Canada, Volume (Units), 2015-2020 26
Table 16: Bone Growth Stimulators Market, Canada, Volume (Units), 2021-2025 26
Table 17: Soft Tissue Biologics Market, Canada, Volume (Units), 2015-2020 28
Table 18: Soft Tissue Biologics Market, Canada, Volume (Units), 2021-2025 28
Table 19: Viscosupplementation Market, Canada, Volume (Units), 2015-2020 30
Table 20: Viscosupplementation Market, Canada, Volume (Units), 2021-2025 31
Table 21: Orthobiologics Market, Canada, Average Price ($), 2015-2020 32
Table 22: Orthobiologics Market, Canada, Average Price ($), 2021-2025 33
Table 23: Orthobiologics Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2017 34
Table 24: Orthobiologics Market, Canada, Company Share by Revenue ($m), USD Constant, 2017 36
Table 25: Orthobiologics Market Pipeline Products 41
Table 26: Ortho Regenerative Technologies to Raise USD1.5 Million in Private Placement of Shares 43
Table 27: Ortho Regenerative Technologies Raises Funds through Private Placement of Shares and Warrants 44
Table 28: Ortho Regenerative Technologies Raises Additional USD0.1 Million in Private Placement of Units 45
Table 29: Ortho Regenerative Technologies Raises USD0.7 Million in First Tranche Private Placement of Units 46
Table 30: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country 52

Figure 1: Orthobiologics Market, Canada, Revenue ($m), USD Constant, 2015-2025 9
Figure 2: Bone Grafts and Substitutes Market, Canada, Revenue ($m), USD Constant, 2015-2025 12
Figure 3: Bone Growth Stimulators Market, Canada, Revenue ($m), USD Constant, 2015-2025 14
Figure 4: Soft Tissue Biologics Market, Canada, Revenue ($m), USD Constant, 2015-2025 16
Figure 5: Viscosupplementation Market, Canada, Revenue ($m), USD Constant, 2015-2025 18
Figure 6: Orthobiologics Market, Canada, Volume (Units), 2015-2025 20
Figure 7: Bone Grafts and Substitutes Market, Canada, Volume (Units), 2015-2025 22
Figure 8: Bone Growth Stimulators Market, Canada, Volume (Units), 2015-2025 25
Figure 9: Soft Tissue Biologics Market, Canada, Volume (Units), 2015-2025 27
Figure 10: Viscosupplementation Market, Canada, Volume (Units), 2015-2025 29
Figure 11: Orthobiologics Market, Canada, Company Share (%) 2017 35

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +